Supply Side Global 2026

SupplySide Global 2026 brought together leading ingredient suppliers, nutraceutical brands, manufacturers, researchers and industry experts from across the global health and nutrition industry to explore emerging ingredient innovations, evolving consumer health priorities and the future of evidence-backed product development.

Representing Vedic Lifesciences at SupplySide Global 2026 in Las Vegas, our team connected with ingredient innovators, brand leaders, scientific advisors and industry professionals to discuss the growing importance of clinical research, scientific substantiation and commercially meaningful health claims.

A recurring theme throughout the event was a fundamental question for ingredient and product innovators: How can clinical evidence translate promising science into a meaningful commercial advantage?

As the nutraceutical industry becomes increasingly competitive, companies are looking beyond product innovation to build stronger scientific credibility. Whether demonstrating the efficacy of an ingredient, substantiating a health claim or differentiating an existing product in the market, robust clinical evidence is becoming an essential component of long-term brand growth.

At SupplySide Global 2026, discussions centred around the role of well-designed clinical trials in demonstrating ingredient value, supporting compliant health claims and building consumer trust. From defining meaningful clinical endpoints and selecting appropriate study populations to determining the right dose and aligning scientific, marketing and regulatory objectives, the conversations highlighted the importance of integrating clinical strategy into product development from the very beginning.

The Evidence Roundtable: Turning Clinical Evidence into a Commercial Advantage

A major highlight of Vedic Lifesciences’ presence at SupplySide Global 2026 was The Evidence Roundtable, an invitation-only scientific discussion that brought together industry experts, legal minds, investors, scientific advisors and Nutra award judges for an evening of candid conversations around clinical evidence. The event was a full house, with an engaged audience exploring some of the industry's most important questions around clinical research. Discussions covered decentralised clinical trials, artificial intelligence in research, study quality, risk mitigation and the challenges of designing studies that deliver both scientific credibility and commercial value.

The Roundtable reinforced an important perspective: clinical evidence should not simply demonstrate efficacy. It should be designed strategically to support meaningful claims, withstand scientific scrutiny and contribute to long-term commercial objectives.

Emerging Opportunities in Clinical Research

SupplySide Global 2026 also provided an opportunity to exchange perspectives on emerging health categories and the evolving evidence requirements of the nutraceutical industry. Conversations highlighted growing interest in women's health, menopausal health, metabolic wellness and GLP-1 companion claims, alongside opportunities to generate stronger clinical evidence for ingredients and products already available in the market.

For Vedic Lifesciences, the event was an opportunity to strengthen relationships with existing partners, connect with new industry stakeholders and continue conversations around clinical trials, claim substantiation, regulatory science and evidence-based product development.

As the industry increasingly recognises the value of clinical research, one principle remains central to our approach: effective clinical research begins with the right scientific question, the right study design and a clear understanding of the claim it needs to support.

SupplySide Global 2026 concluded with meaningful conversations, new connections and exciting opportunities for future collaboration.

We thank everyone who visited Booth #5236, joined The Evidence Roundtable and shared their perspectives with our team.

At Vedic Lifesciences, we remain committed to helping health and nutrition innovators translate promising science into credible evidence, compliant claims and clinically proven outcomes.

SupplySide Global 2026 may be over, but the conversations are just getting started.

Here's to turning promising ideas into meaningful evidence and evidence into commercial advantage.